BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33409616)

  • 41. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
    D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.
    Pezuk JA; Valera ET; Delsin LE; Scrideli CA; Tone LG; Brassesco MS
    Cent Nerv Syst Agents Med Chem; 2015; 16(1):67-72. PubMed ID: 26553097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BMI1 is a therapeutic target in recurrent medulloblastoma.
    Bakhshinyan D; Venugopal C; Adile AA; Garg N; Manoranjan B; Hallett R; Wang X; Mahendram S; Vora P; Vijayakumar T; Subapanditha M; Singh M; Kameda-Smith MM; Qazi M; McFarlane N; Mann A; Ajani OA; Yarascavitch B; Ramaswamy V; Farooq H; Morrissy S; Cao L; Sydorenko N; Baiazitov R; Du W; Sheedy J; Weetall M; Moon YC; Lee CS; Kwiecien JM; Delaney KH; Doble B; Cho YJ; Mitra S; Kaplan D; Taylor MD; Davis TW; Singh SK
    Oncogene; 2019 Mar; 38(10):1702-1716. PubMed ID: 30348991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma.
    Lee JW; Lim DH; Sung KW; Cho HW; Ju HY; Hyun JK; Yoo KH; Koo HH; Suh YL; Joung YS; Shin HJ
    Cancer Med; 2020 Aug; 9(16):5807-5818. PubMed ID: 32608158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. B7-H3 in Medulloblastoma-Derived Exosomes; A Novel Tumorigenic Role.
    Purvis IJ; Velpula KK; Guda MR; Nguyen D; Tsung AJ; Asuthkar S
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis.
    Pezuk JA; Brassesco MS; de Oliveira RS; Machado HR; Neder L; Scrideli CA; Tone LG
    Childs Nerv Syst; 2017 Apr; 33(4):609-615. PubMed ID: 28283778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteomic analysis of extracellular vesicles from medullospheres reveals a role for iron in the cancer progression of medulloblastoma.
    Bisaro B; Mandili G; Poli A; Piolatto A; Papa V; Novelli F; Cenacchi G; Forni M; Zanini C
    Mol Cell Ther; 2015; 3():8. PubMed ID: 26464805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
    Gupta T; Shirsat N; Jalali R
    Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
    Amlashi SF; Riffaud L; Brassier G; Morandi X
    Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New Approaches in Targeted Therapy for Medulloblastoma in Children.
    Maier H; Dalianis T; Kostopoulou ON
    Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medulloblastoma and Collins' law: a critical review of the concept of a period of risk for tumor recurrence and patient survival.
    Brown WD; Tavaré CJ; Sobel EL; Gilles FH
    Neurosurgery; 1995 Apr; 36(4):691-7. PubMed ID: 7596498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.
    Okolie O; Irvin DM; Bago JR; Sheets K; Satterlee A; Carey-Ewend AG; Lettry V; Dumitru R; Elton S; Ewend MG; Miller CR; Hingtgen SD
    PLoS One; 2018; 13(7):e0198596. PubMed ID: 29990322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
    Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
    Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Challenges and Recent Advances in Medulloblastoma Therapy.
    Kumar V; Kumar V; McGuire T; Coulter DW; Sharp JG; Mahato RI
    Trends Pharmacol Sci; 2017 Dec; 38(12):1061-1084. PubMed ID: 29061299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma.
    Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY
    Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
    von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA
    BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
    Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
    Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analysis of pathologic characteristics and prognosis in different subtypes of adult medulloblastoma].
    Zhao F; Zhang J; Wang X; Wang Z; Wang Y; Qu P; Luo L; Liu P
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):169-72. PubMed ID: 24842015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.